patent for semaglutide Ozempic's problem: how Novo Nordisk lost control of a blockbuster drug. π Demand GLP-1 weight-loss drugs has exploded, turning Ozempic into a $40bn+ revenue engine for Novo Nordisk. But, despite Obesity Drugs Set To Take
Pay in 4 interest-free payments of $7.25 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Jul 31 - Aug 5




)




















